Clinical Trial Update: Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether low-dose testosterone improves libido in postmenopausal female cancer survivors; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Testosterone (low-dose) (testosterone)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Cancer Survivor, Sexual Dysfunction | Phase 3 | Status: COMPLETED